These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1724099)

  • 21. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rheologic effects of normovolemic hemodilution].
    Kuznetsov NA; Aleksandrova NP; Bogdanov AE; Rogulenko RV
    Anesteziol Reanimatol; 1990; (2):18-22. PubMed ID: 1698041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodilution in patients with peripheral arterial occlusive disease.
    Kiesewetter H; Jung F; Erdlenbruch W; Wenzel E
    Int Angiol; 1992; 11(3):169-75. PubMed ID: 1281205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pruritus--a side effect of hydroxyethyl starch? First report].
    Schneeberger R; Albegger K; Oberascher G; Miller K
    HNO; 1990 Aug; 38(8):298-303. PubMed ID: 1699918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavior of tissue oxygen pressure in skeletal muscle of patients with peripheral arterial occlusive disease in simulated altitude stress].
    Landgraf H; Schulte-Huermann D; Ehrly AM
    Vasa Suppl; 1991; 32():247-51. PubMed ID: 1771507
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemodilution with dextran 40 and hydroxyethyl starch and its effect on cerebral microcirculation.
    Scharf J; von Kummer R; Back T; Reich H; Machens G; Wildemann B
    J Neurol; 1989 Mar; 236(3):164-7. PubMed ID: 2468744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemodilution in peripheral arterial occlusive disease].
    Becsi C; Wehofer D; Weidinger P
    Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
    [No Abstract]   [Full Text] [Related]  

  • 29. [The metabolism of organ cultures of cornea in TC 199 with added dextran 500 or hydroxyethyl starch 450].
    Reim M; Hesse R; Pietruschka G
    Klin Monbl Augenheilkd; 1990 Feb; 196(2):76-80. PubMed ID: 1691324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
    Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
    Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb.
    Kiesewetter H; Blume J; Jung F; Spitzer S; Wenzel E
    J Intern Med; 1990 Feb; 227(2):107-14. PubMed ID: 1688914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
    Höffkes HG; Saeger-Lorenz K; Ehrly AM
    Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The walking-through phenomenon in arterial occlusive disease].
    Maass U; Goller B; Grothe R; Schneider B
    Vasa; 1995; 24(3):233-7. PubMed ID: 7676731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Organ blood supply and oxygenation during limited isovolemic hemodilution with 6% HES 200/0.62 and 6% Dextran 70].
    Brückner UB; Messmer K
    Anaesthesist; 1991 Aug; 40(8):434-40. PubMed ID: 1719841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conservative therapy of peripheral arterial occlusive diseases].
    Alexander K
    Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolic studies of muscles and blood in ergometrically stressed patients with arterial occlusive disease].
    Nissen P; Alexander K; Maass U
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():176. PubMed ID: 613562
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biochemical modifications in stress ischemia of the calf muscles].
    Rexroth W; Hild R
    Vasa Suppl; 1991; 32():562-71. PubMed ID: 1771582
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood regeneration after blood substitution with dextran 60 or hydroxyethyl starch of an identical volume].
    Hölscher B; Kagel S
    Infusionsther Klin Ernahr; 1976 Aug; 3(4):250-3. PubMed ID: 60284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.